Search research articles
Contact Us
Filters
Showing results (1291-1300 of 1,501) with videos related to
Page
of 151
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
May 15, 2020
Chloroplast Sec14-like 1 (CPSFL1) is essential for normal chloroplast development and affects carotenoid accumulation in <i>Chlamydomonas</i>
José G García-Cerdán, Eva M Schmid, Tomomi Takeuchi, et al.
Journal of the American Chemical Society
|
November 10, 2005
Detection of homocysteine and cysteine
Weihua Wang, Oleksandr Rusin, Xiangyang Xu, et al.
The Journal of Physiology
|
May 16, 2017
Aerobic capacity mediates susceptibility for the transition from steatosis to steatohepatitis
E Matthew Morris, Colin S McCoin, Julie A Allen, et al.
Tuberculosis (Edinburgh, Scotland)
|
September 20, 2008
A comparison of IFNgamma detection methods used in tuberculosis vaccine trials
Natalie E R Beveridge, Helen A Fletcher, Jane Hughes, et al.
Plos One
|
August 14, 2008
Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa
Roger H Brookes, Philip C Hill, Patrick K Owiafe, et al.
Journal of Neurosurgery. Pediatrics
|
March 25, 2023
The significance of hindbrain herniation reversal following prenatal repair of neural tube defects
Clifton O Brock, Eric P Bergh, Michal Fishel Bartal, et al.
Urologic Oncology
|
February 19, 2018
The effect of treatment at minority-serving hospitals on outcomes for bladder cancer
Sean A Fletcher, Philipp Gild, Alexander P Cole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT
Charles D Blanke, George D Demetri, Margaret von Mehren, et al.
Vaccine
|
May 11, 2020
A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy
Suresh Pallikkuth, Hector Bolivar, Mary A Fletcher, et al.
Clinical and Vaccine Immunology : CVI
|
May 16, 2014
Process of assay selection and optimization for the study of case and control samples from a phase IIb efficacy trial of a candidate tuberculosis vaccine, MVA85A
Stephanie A Harris, Iman Satti, Magali Matsumiya, et al.
Page
of 151
Search research articles
Search
Showing results (1291-1300 of 1,501) with videos related to
Sort By:
Page
of 151
Proceedings of the National Academy of Sciences of the United States of America
|
May 15, 2020
Chloroplast Sec14-like 1 (CPSFL1) is essential for normal chloroplast development and affects carotenoid accumulation in <i>Chlamydomonas</i>
José G García-Cerdán, Eva M Schmid, Tomomi Takeuchi, et al.
Journal of the American Chemical Society
|
November 10, 2005
Detection of homocysteine and cysteine
Weihua Wang, Oleksandr Rusin, Xiangyang Xu, et al.
The Journal of Physiology
|
May 16, 2017
Aerobic capacity mediates susceptibility for the transition from steatosis to steatohepatitis
E Matthew Morris, Colin S McCoin, Julie A Allen, et al.
Tuberculosis (Edinburgh, Scotland)
|
September 20, 2008
A comparison of IFNgamma detection methods used in tuberculosis vaccine trials
Natalie E R Beveridge, Helen A Fletcher, Jane Hughes, et al.
Plos One
|
August 14, 2008
Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa
Roger H Brookes, Philip C Hill, Patrick K Owiafe, et al.
Journal of Neurosurgery. Pediatrics
|
March 25, 2023
The significance of hindbrain herniation reversal following prenatal repair of neural tube defects
Clifton O Brock, Eric P Bergh, Michal Fishel Bartal, et al.
Urologic Oncology
|
February 19, 2018
The effect of treatment at minority-serving hospitals on outcomes for bladder cancer
Sean A Fletcher, Philipp Gild, Alexander P Cole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT
Charles D Blanke, George D Demetri, Margaret von Mehren, et al.
Vaccine
|
May 11, 2020
A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy
Suresh Pallikkuth, Hector Bolivar, Mary A Fletcher, et al.
Clinical and Vaccine Immunology : CVI
|
May 16, 2014
Process of assay selection and optimization for the study of case and control samples from a phase IIb efficacy trial of a candidate tuberculosis vaccine, MVA85A
Stephanie A Harris, Iman Satti, Magali Matsumiya, et al.
Page
of 151